Salix Pharmaceuticals Announces 1Q2013 Financial Results Conference Call and Webcast
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the
Company will report first quarter 2013 financial results following the
close of the U.S. financial markets on Thursday, May 9, 2013.
The Company will host a conference call at 5:00 p.m. ET on Thursday, May
9, 2013. Interested parties can access the conference call by way of web
cast or telephone. The live web cast will be available at www.salix.com.
A replay of the web cast will be available at the same location. The
telephone numbers to access the live conference call are (877) 756-4253
(U.S. and Canada) or (706) 902-2163 (international.) The telephone
numbers to access the replay of the call are (855) 859-2056 or (800)
585-8367 (U.S. and Canada) or (404) 537-3406 (international). The access
code for the call is 55050396.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina,
develops and markets prescription pharmaceutical products for the
prevention and treatment of gastrointestinal diseases. Salix’s strategy
is to in-license late-stage or marketed proprietary therapeutic drugs,
complete any required development and regulatory submission of these
products, and market them through the Company’s gastroenterology
specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol
"SLXP".
For more information, please visit our Website at www.salix.com
or contact the Company at 919–862–1000. Follow us on Twitter
(@SalixPharma) and Facebook (www.facebook.com/SalixPharma)
Information on our web site is not incorporated in our SEC filings.
